HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer

June 17, 2026 · 1h 28m · Season 24 · Episode 23

About this episode

This episode discusses HER2-positive gynecologic cancers and features insights from leading experts in the field.

Featuring perspectives from Dr Joyce F Liu, Dr David M O’Malley and Dr Brian M Slomovitz, moderated by Dr O’Malley, including the following topics: Introduction (0:00) Strategies to Identify Patients with HER2-Positive Gynecologic Cancers — Dr Liu (2:52) Available Data with and Practical Application of HER2-Targeted Therapy in Advanced Gynecologic Cancers — Dr Slomovitz (25:16) Identification and Management of Adverse Events with Trastuzumab Deruxtecan — Dr O’Malley (1:00:31) CME information and select publications

People in this episode

Host: Dr David M O’Malley

Guests: Dr Joyce F Liu, Dr Brian M Slomovitz

Topics covered

Keywords

Mentioned in this episode

Organizations: Society of Gynecologic Oncology

Products: Trastuzumab Deruxtecan

More episodes of Gynecologic Oncology Update

Explore listener stats, chart rankings, contacts and more on the Gynecologic Oncology Update podcast page.